The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

NCT07200596 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: SHR-3045 Injection
DRUG: SHR-3045 Placebo Injection

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd